Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic steatohepatitis.
President Donald Trump had his annual physical. He weighs 243 pounds and stands six feet and three inches tall. That gives him a body mass index of 30.4, which is considered “obese.” About 40%…
On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused on lung cancer.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in most of the…
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Around 4.9 million middle and high school students used tobacco in 2018. That is up from 3.6 million in 2017, a 36% increase. Virtually the entire increase was due to e-cigarette use. The Centers…
It is supposed to be undeniable that smoking and using any forms of tobacco is bad for your health. And the rate of smoking cigarettes has been on the decline for years and years…
The U.S. FDA and the FTC have sent warning letters to three makers and distributors of products that make unsubstantiated claims of providing relief or cures from a variety of diseases, including Alzheimer's.
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Solid Bio shares were absolutely crushed on Thursday after preliminary data from the firm’s midstage trial in Duchenne muscular dystrophy was not up to par.